BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia have?
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia has 225 citations in the OpenAlex counts ScholarIQ stores.
When was BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia published?
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia has 2002 year in the ScholarIQ index.
What is the open-access status of BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia has closed oa status in the ScholarIQ index.
What is the DOI of BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
The DOI for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is on the source record.
What is the PMID of BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
The PMID for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is on the source record.
What is the OpenAlex record for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia?
The OpenAlex for BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia is on the source record.